AFP and hepatocellular carcinoma: In the context of HCC, prognostic assessment remains limited by the low sensitivity and specificity of conventional surveillance tools such as ultrasonography and serum AFP.[30] Although our platform showed lower diagnostic performance relative to standard serum biomarkers, likely due to low PD‐L1 tissue expression in HCC,[22, 23] it demonstrated superior prognostic relevance.